Clinical trials

  • XELAFASLATIDE for Atrophic age-related macular degeneration (geographic atrophy)
  • Clinical trial in Gastroenteropancreatic neuroendocrine tumor (well-differentiated, locally advanced or metastatic)
  • OATD-02 for Advanced solid tumours | Colorectal cancer | Ovarian cancer | Pancreatic cancer | Renal cell carcinoma
  • SEMAGLUTIDE for HIV infection | Obesity
  • ABEMACICLIB for Metastatic breast cancer | Estrogen receptor-positive HER2-negative breast cancer
  • Pembrolizumab for Metastatic non-small cell lung cancer (PD-L1 TPS ≥50%)
  • PREDNISONE for Hepatotoxicity
  • INDOCYANINE GREEN for Breast cancer
  • CAPECITABINE for Gastric adenocarcinoma | Oesophageal adenocarcinoma | Gastroesophageal junction adenocarcinoma
  • PEMBROLIZUMAB for Melanoma | Non-small cell lung cancer | Non-squamous non-small cell lung cancer
  • ACASUNLIMAB for Non-small cell lung cancer
  • BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX for Spastic equinovarus (post-stroke) | First-ever unilateral stroke